4.7 Article

Vitamin D in human serum and adipose tissue after supplementation

Journal

AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume 113, Issue 1, Pages 83-91

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ajcn/nqaa295

Keywords

vitamin D; ergocalciferol; cholecalciferol; validation; Clinical and Laboratory Standards Institute; liquid-liquid extraction; liquid chromatography-tandem mass spectrometry

Funding

  1. National Heart, Lung, and Blood Institute [T32HL007028, R01HL096875]
  2. NIH [KL2RR025015, UL1TR002319, P30DK035816]
  3. National Institute of Diabetes and Digestive and Kidney Diseases [P30DK017047, R01DK099199, R01DK088762]

Ask authors/readers for more resources

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for quantification of vitamins D3 and D2 in serum. Results from two pilot clinical trials showed that serum and subcutaneous adipose tissue vitamin D3 concentrations increased proportionally to dose with 3 months of daily supplementation.
Background: Serum 25-hydroxyvitamin D [25(OH)D] concentration is an indicator of vitamin D exposure, but it is also influenced by clinical characteristics that affect 25(OH)D production and clearance. Vitamin D is the precursor to 25(OH)D but is analytically challenging to measure in biological specimens. Objectives: We aimed to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification of vitamins D3 and D2 in serum and to explore the potential of circulating vitamin D as a biomarker of exposure in supplementation trials. Methods: The method was validated using guideline C62-A from the Clinical and Laboratory Standards Institute and was applied in 2 pilot clinical trials of oral vitamin D3 supplementation. Pilot study 1 included 22 adults randomly assigned to placebo or 2000 IU/d. Blood was collected at baseline, 1, 3, 6, and 12 mo. Pilot study 2 included 15 adults randomly assigned to 2000 or 4000 IU/d. Blood and subcutaneous (SUBQ) adipose tissue were collected at baseline and 3 mo. Results: In study 1, mean change (baseline to 3 mo) in serum vitamin D3 was -0.1 ng/mL in the placebo group and 6.8 ng/mL in the 2000 IU/d group (absolute difference: 6.9; 95% CI: 4.5, 9.3 ng/mL). In study 2, mean change (baseline to 3 mo) in serum vitamin D3 was 10.4 ng/mL in the 2000 IU/d group and 22.2 ng/mL in the 4000 IU/d group (fold difference: 2.15; 95% CI: 1.40, 3.37). Serum and adipose tissue vitamin D3 concentrations were correlated, and the dose-response of vitamin D3 in adipose mirrored that in serum. Conclusions: We validated a sensitive, robust, and high-throughput LC-MS/MS method to quantify vitamins D3 and D2 in serum. Serum and SUBQ adipose tissue vitamin D3 concentrations increased proportionally to dose with 3 mo of daily supplementation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available